GLAND PHARMA
Back to All Ratios
|
GLAND PHARMA Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 16.15 | 19.17 | 13.54 | 29.19 | 26.12 |
What is the latest EV/Core EBITDA ratio of GLAND PHARMA ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 16.15 |
| Mar2024 | 19.17 |
| Mar2023 | 13.54 |
| Mar2022 | 29.19 |
| Mar2021 | 26.12 |
How is EV/Core EBITDA of GLAND PHARMA Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 16.15 | -15.75 | |
| Mar2024 | 19.17 | 41.58 | |
| Mar2023 | 13.54 | -53.61 | |
| Mar2022 | 29.19 | 11.75 | |
| Mar2021 | 26.12 | - | |
Other Financial Ratios of GLAND PHARMA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹28,672.7 Cr | 2.3% | 3.6% | 11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.3% |
3.6% |
11.8% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses